ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cellectis (PK)

Cellectis (PK) (CMVLF)

3.47
0.00
(0.00%)
終了 6月12日 5:00AM

Cellectis (PK) (CMVLF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
3.47
( - )
買値
0.01
売値
6,003.70
出来高
-
0.00 日の範囲 0.00
2.58 52 週間の範囲 5.04
時価総額
前日終値
3.47
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 301,736
発行済株式数
72,601,869
配当利回り
PER
-4.34
1 株当たり利益 (EPS)
-0.67
歳入
75.11M
純利益
-67.23M

Cellectis (PK) について

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is ... Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Paris, France
設立
1999
Cellectis (PK) is listed in the Healthcare sector of the その他OTC with ticker CMVLF. The last closing price for Cellectis (PK) was US$3.47. Over the last year, Cellectis (PK) shares have traded in a share price range of US$ 2.58 to US$ 5.04.

Cellectis (PK) currently has 72,601,869 shares in issue. The market capitalisation of Cellectis (PK) is US$251.93 million. Cellectis (PK) has a price to earnings ratio (PE ratio) of -4.34.

CMVLF 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
4003.473.473.4714003.47CS
120.3912.66233766233.083.473.083403.40117647CS
26-1.03-22.88888888894.54.53.081903.50631579CS
520.8934.4961240312.585.042.581823.83105691CS
1561.42569.68215158922.0455.040.953032.63205351CS
260-12.58-78.380062305316.0516.050.954234.71213473CS

CMVLF - Frequently Asked Questions (FAQ)

What is the current Cellectis (PK) share price?
The current share price of Cellectis (PK) is US$ 3.47
How many Cellectis (PK) shares are in issue?
Cellectis (PK) has 72,601,869 shares in issue
What is the market cap of Cellectis (PK)?
The market capitalisation of Cellectis (PK) is USD 251.93M
What is the 1 year trading range for Cellectis (PK) share price?
Cellectis (PK) has traded in the range of US$ 2.58 to US$ 5.04 during the past year
What is the PE ratio of Cellectis (PK)?
The price to earnings ratio of Cellectis (PK) is -4.34
What is the cash to sales ratio of Cellectis (PK)?
The cash to sales ratio of Cellectis (PK) is 2.81
What is the registered address of Cellectis (PK)?
The registered address for Cellectis (PK) is 8, rue de la Croix Jarry, Paris, Ile-de-France, 75013
What is the Cellectis (PK) website address?
The website address for Cellectis (PK) is www.cellectis.com
Which industry sector does Cellectis (PK) operate in?
Cellectis (PK) operates in the Biotechnology & Life Sciences sector

CMVLF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

CMVLF Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock